| scholarly article | Q13442814 |
| P50 | author | Olov Wiklund | Q76506012 |
| Nader Rifai | Q87727132 | ||
| Grazyna Sypniewska | Q90682326 | ||
| Alan T. Remaley | Q91944002 | ||
| Florian Kronenberg | Q28039325 | ||
| Emilio Ros | Q38543979 | ||
| Arnold von Eckardstein | Q41607665 | ||
| Jan Borén | Q42048764 | ||
| Børge G. Nordestgaard | Q43530123 | ||
| Gerald Watts | Q71943021 | ||
| P2093 | author name string | Eric Bruckert | |
| Pia R Kamstrup | |||
| Samia Mora | |||
| Anne Langsted | |||
| Genovefa Kolovou | |||
| M John Chapman | |||
| Olivier S Descamps | |||
| Michel Langlois | |||
| Kari Pulkki | |||
| Hannsjörg Baum | |||
| Christa Cobbaert | |||
| P2860 | cites work | Lipoprotein(a)-cholesterol: a significant component of serum cholesterol | Q84358732 |
| Lipoprotein(a) as a cardiovascular risk factor: current status | Q24623225 | ||
| Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease: consensus statement of the European Atherosclerosis Society | Q27024882 | ||
| Triglycerides and cardiovascular disease: a scientific statement from the American Heart Association | Q28235865 | ||
| Evaluation of methods for the measurement of low-density lipoprotein cholesterol. | Q29547378 | ||
| 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines | Q29620108 | ||
| Homozygous familial hypercholesterolaemia: new insights and guidance for clinicians to improve detection and clinical management. A position paper from the Consensus Panel on Familial Hypercholesterolaemia of the European Atherosclerosis Society | Q34071937 | ||
| Triglyceride-rich lipoproteins and high-density lipoprotein cholesterol in patients at high risk of cardiovascular disease: evidence and guidance for management | Q34181381 | ||
| ESC/EAS Guidelines for the management of dyslipidaemias: the Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS). | Q34196167 | ||
| Fasting time and lipid levels in a community-based population: a cross-sectional study | Q34311357 | ||
| Remnant cholesterol as a causal risk factor for ischemic heart disease | Q34319441 | ||
| The polygenic nature of hypertriglyceridaemia: implications for definition, diagnosis, and management | Q34359967 | ||
| Comparison of a novel method vs the Friedewald equation for estimating low-density lipoprotein cholesterol levels from the standard lipid profile | Q34481404 | ||
| Fasting might not be necessary before lipid screening: a nationally representative cross-sectional study | Q35187361 | ||
| Major lipids, apolipoproteins, and risk of vascular disease | Q35771393 | ||
| Identifying an Optimal Cutpoint for the Diagnosis of Hypertriglyceridemia in the Nonfasting State | Q36011783 | ||
| Familial hypercholesterolaemia in children and adolescents: gaining decades of life by optimizing detection and treatment. | Q36076131 | ||
| Fasting compared with nonfasting lipids and apolipoproteins for predicting incident cardiovascular events | Q36952948 | ||
| Genetic associations with valvular calcification and aortic stenosis | Q37154922 | ||
| Comparison of LDL cholesterol concentrations by Friedewald calculation and direct measurement in relation to cardiovascular events in 27,331 women | Q37218287 | ||
| Triglycerides and cardiovascular disease | Q38240749 | ||
| Fasting compared with nonfasting triglycerides and risk of cardiovascular events in women | Q40192779 | ||
| Comparison of low-density lipoprotein cholesterol concentrations measured by a direct homogeneous assay and by the Friedewald formula in a large community population | Q42945313 | ||
| Elevated remnant cholesterol causes both low-grade inflammation and ischemic heart disease, whereas elevated low-density lipoprotein cholesterol causes ischemic heart disease without inflammation | Q44013806 | ||
| Genetically elevated lipoprotein(a) and increased risk of myocardial infarction | Q44238417 | ||
| Nonfasting triglycerides and risk of ischemic stroke in the general population | Q44734713 | ||
| Fasting and nonfasting lipid levels: influence of normal food intake on lipids, lipoproteins, apolipoproteins, and cardiovascular risk prediction | Q46291367 | ||
| Nonfasting lipids, lipoproteins, and apolipoproteins in individuals with and without diabetes: 58 434 individuals from the Copenhagen General Population Study | Q46887682 | ||
| Nonfasting Lipid Profiles: The Way of the Future | Q48427448 | ||
| European Guidelines on cardiovascular disease prevention in clinical practice (version 2012). The Fifth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted | Q48527068 | ||
| Prognostic value of fasting versus nonfasting low-density lipoprotein cholesterol levels on long-term mortality: insight from the National Health and Nutrition Examination Survey III (NHANES-III). | Q51319144 | ||
| Lipoprotein(a): fasting and nonfasting levels, inflammation, and cardiovascular risk. | Q51325629 | ||
| Standardization of collection requirements for fasting samples: for the Working Group on Preanalytical Phase (WG-PA) of the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM). | Q51330933 | ||
| Fasting for lipid testing: Is it worth the trouble? | Q51344848 | ||
| Should we fast before we measure our lipids? | Q51344920 | ||
| Daytime triglyceride variability in men and women with different levels of triglyceridemia. | Q51369118 | ||
| Using nonfasting lipids--hemodilution or convenience? | Q51371289 | ||
| Assessment and clinical relevance of non-fasting and postprandial triglycerides: an expert panel statement. | Q51379451 | ||
| Diagnostic value of postprandial triglyceride testing in healthy subjects: a meta-analysis. | Q51379457 | ||
| Whither the lipid profile: feast, famine, or no free lunch? | Q51381563 | ||
| [Plasma lipids in non-fasting patients and signal values of laboratory results]. | Q51428407 | ||
| Lipoprotein cholesterol concentrations in the plasma of human subjects as measured in the fed and fasted states. | Q51623691 | ||
| Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. | Q51679983 | ||
| Do enzymatic analyses of serum triglycerides really need blanking for free glycerol? | Q54458317 | ||
| Elevated lipoprotein(a) and risk of aortic valve stenosis in the general population. | Q54694067 | ||
| Triglycerides and the Risk of Coronary Heart Disease | Q57267183 | ||
| Nonfasting Triglycerides and Risk of Myocardial Infarction, Ischemic Heart Disease, and Death in Men and Women | Q61162458 | ||
| P433 | issue | 25 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | atherosclerosis | Q12252367 |
| P304 | page(s) | 1944-58 | |
| P577 | publication date | 2016-07-01 | |
| P1433 | published in | European Heart Journal | Q2286839 |
| P1476 | title | Fasting is not routinely required for determination of a lipid profile: clinical and laboratory implications including flagging at desirable concentration cut-points-a joint consensus statement from the European Atherosclerosis Society and European Federation of Clinical Chemistry and Laboratory Medicine | |
| P478 | volume | 37 |
| Q50547169 | A consensus statement on lipid management after acute coronary syndrome. |
| Q37574714 | A novel approach to screening for familial hypercholesterolemia in a large public venue |
| Q40104818 | ANMCO/ISS/AMD/ANCE/ARCA/FADOI/GICR-IACPR/SICI-GISE/SIBioC/SIC/SICOA/SID/SIF/SIMEU/SIMG/SIMI/SISA Joint Consensus Document on cholesterol and cardiovascular risk: diagnostic-therapeutic pathway in Italy |
| Q48136448 | Absolute versus relative measures of plasma fatty acids and health outcomes: example of phospholipid omega-3 and omega-6 fatty acids and all-cause mortality in women. |
| Q33587438 | Accuracy of low-density lipoprotein cholesterol estimation at very low levels |
| Q58580165 | Adaptation of 2016 European Society of Cardiology/European Atherosclerosis Society guideline for lipid management to Indian patients - A consensus document |
| Q92708052 | Age-specific and sex-specific reference intervals for non-fasting lipids and apolipoproteins in 7260 healthy Chinese children and adolescents measured with an Olympus AU5400 analyser: a cross-sectional study |
| Q37286652 | Alterations in Serum Polyunsaturated Fatty Acids and Eicosanoids in Patients with Mild to Moderate Chronic Obstructive Pulmonary Disease (COPD) |
| Q64964905 | Association between circulating full-length angiopoietin-like protein 8 and non-high-density lipoprotein cholesterol levels in Chinese non-diabetic individuals: a cross-sectional study. |
| Q64461056 | Association between fat mass through adolescence and arterial stiffness: a population-based study from The Avon Longitudinal Study of Parents and Children |
| Q55428280 | Association of anthropometric measures and cardiovascular risk factors in children and adolescents: Findings from the Aboriginal Birth Cohort study. |
| Q97419002 | Can we walk away from cardiovascular disease risk or do we have to 'huff and puff'? A cross-sectional compositional accelerometer data analysis among adults and older adults in the Copenhagen City Heart Study |
| Q64996632 | Cardiovascular disease risk associated with elevated lipoprotein(a) attenuates at low low-density lipoprotein cholesterol levels in a primary prevention setting. |
| Q61809847 | Challenges in the classification and management of Asian youth-onset diabetes mellitus- lessons learned from a single centre study |
| Q56243477 | Cholesterol profile in women with premature menopause after risk reducing salpingo-oophorectomy |
| Q48318089 | Chylomicronemia risk factors ranked by importance for the individual and community in 108 711 women and men. |
| Q51764443 | Clinical and Genetic Risk Factors for Adverse Metabolic Outcomes in North American Testicular Cancer Survivors. |
| Q47115413 | Comparative Agreement Analysis of Differences in 1,5-Anhydroglucitol, Glycated Albumin, and Glycated Hemoglobin A1c Levels between Fasting and Postprandial States in Steamed Bread Meal Test. |
| Q96299383 | Comparison of calculated remnant lipoprotein cholesterol levels with levels directly measured by nuclear magnetic resonance |
| Q90601933 | Comparison of nonfasting and fasting lipoprotein subfractions and size in 15,397 apparently healthy individuals: An analysis from the VITamin D and OmegA-3 TriaL |
| Q59336288 | Counterpoint: Flexibilization of Fasting for Laboratory Determination of the Lipid Profile in Brazil: Science or Convenience? |
| Q89110431 | Determinants of Achieved LDL Cholesterol and "Non-HDL" Cholesterol in the Management of Dyslipidemias |
| Q33752261 | Determination of Fasting and Non-Fasting Cholesterol Levels of Low- and High-Density Lipoproteins with Homogenous Assays: A Promising Reliable Way to Assessment of Dyslipidemia |
| Q51131854 | Dietary fat and physiological determinants of plasma chylomicron remnant homoeostasis in normolipidaemic subjects: insight into atherogenic risk. |
| Q89184135 | Discrepancies Between BMI and Classic Cardiovascular Risk Factors |
| Q53644756 | Dyslipidaemias: new mechanistic insights and the 2016 ESC Guidelines. |
| Q38859167 | Dyslipidemia after pediatric renal transplantation-The impact of immunosuppressive regimens |
| Q54204331 | Dyslipidemia among rural and urban HIV patients in south-east Malawi. |
| Q53818426 | Effects of Virgin Olive Oils Differing in Their Bioactive Compound Contents on Metabolic Syndrome and Endothelial Functional Risk Biomarkers in Healthy Adults: A Randomized Double-Blind Controlled Trial. |
| Q55072078 | Effects of a School-Based Sports Program on Physical Fitness, Physical Activity, and Cardiometabolic Health in Youth With Physical Disabilities: Data From the Sport-2-Stay-Fit Study. |
| Q38903993 | Effects of dyslipidaemia on monocyte production and function in cardiovascular disease |
| Q40238320 | Extreme high high-density lipoprotein cholesterol is paradoxically associated with high mortality in men and women: two prospective cohort studies |
| Q90608290 | Ezetimibe in Combination With Simvastatin Reduces Remnant Cholesterol Without Affecting Biliary Lipid Concentrations in Gallstone Patients |
| Q92890701 | Familial hypercholesterolaemia: evolving knowledge for designing adaptive models of care |
| Q89942534 | Fasting and postprandial lipid parameters: A comparative evaluation of cardiovascular risk assessment in prediabetes and diabetes |
| Q47126780 | Fasting conditions: Influence of water intake on clinical chemistry analytes |
| Q49892977 | Fasting or Non-fasting Lipids for Atherosclerotic Cardiovascular Disease Risk Assessment and Treatment? |
| Q93353974 | Fasting-Evoked En Route Hypoglycemia in Diabetes (FEEHD): An Overlooked Form of Hypoglycemia in Clinical Practice |
| Q59329833 | Flexibilization of Fasting for Laboratory Determination of the Lipid Profile in Brazil: Science or Convenience? |
| Q38739884 | HDL cholesterol: reappraisal of its clinical relevance |
| Q50558071 | High density lipoproteins and type 2 inflammatory biomarkers are negatively correlated in atopic asthmatics. |
| Q90586458 | Household air pollution from biomass-burning cookstoves and metabolic syndrome, blood lipid concentrations, and waist circumference in Honduran women: A cross-sectional study |
| Q38824417 | How to implement clinical guidelines to optimise familial hypercholesterolaemia diagnosis and treatment |
| Q39181612 | Hypertriglyceridaemia and risk of coronary artery disease |
| Q59353533 | Hypertriglyceridaemia and the risk of pancreatitis six months post lopinavir/ritonavir initiation |
| Q47180199 | Hypertriglyceridemia and atherosclerosis |
| Q90319721 | Identification of a threshold to discriminate fasting hypertriglyceridemia with postprandial values |
| Q58362346 | Japan Atherosclerosis Society (JAS) Guidelines for Prevention of Atherosclerotic Cardiovascular Diseases 2017 |
| Q39431228 | Knowns and unknowns in the care of pediatric familial hypercholesterolemia |
| Q38825512 | Lipid Biomarkers for Risk Assessment in Acute Coronary Syndromes |
| Q41659678 | Lipid Profiles, Glycated Hemoglobin, and Diabetes in People Living at High Altitude in Nepal |
| Q90319529 | Lipid management for coronary heart disease patients: an appraisal of updated international guidelines applying Appraisal of Guidelines for Research and Evaluation II-clinical practice guideline appraisal for lipid management in coronary heart disea |
| Q90193404 | Lipids, Lipoprotein Distribution and Nutritional Parameters over the Ramadan Period in Hemodialysis Patients |
| Q28078664 | Lipoprotein apheresis in the management of severe hypercholesterolemia and of elevation of lipoprotein(a): current perspectives and patient selection |
| Q64953695 | Liraglutide treatment improves postprandial lipid metabolism and cardiometabolic risk factors in humans with adequately controlled type 2 diabetes: A single-centre randomized controlled study. |
| Q89907432 | Metabolic Parameters in Patients with Prader-Willi Syndrome and DiGeorge Syndrome with Respect to Psychopathological Manifestation |
| Q96229937 | Metabolic syndrome does not influence the phenotype of LRRK2 and GBA related Parkinson's disease |
| Q95729268 | National trends in total cholesterol obscure heterogeneous changes in HDL and non-HDL cholesterol and total-to-HDL cholesterol ratio: a pooled analysis of 458 population-based studies in Asian and Western countries |
| Q64247691 | Non-fasting High-Density Lipoprotein Is Associated With White Matter Microstructure in Healthy Older Adults |
| Q64055910 | Non-fasting lipids detection and their significance in pregnant women |
| Q50046562 | Non-fasting triglyceride levels in the Korean population with and without ischemic heart disease and cerebrovascular disease. |
| Q55315345 | Nonfasting Apo-lipoprotein B and Triglyceride levels as a predictor of coronary heart disease in Type II diabetic patients. |
| Q55111553 | Novel method versus the Friedewald method for estimating low-density lipoprotein cholesterol in determination of the eligibility for statin treatment for primary prevention in the United States. |
| Q58111036 | Pan-Genotypic Hepatitis C Treatment with Glecaprevir and Pibrentasvir for 8 Weeks Resulted in Improved Cardiovascular and Metabolic Outcomes and Stable Renal Function: A Post-Hoc Analysis of Phase 3 Clinical Trials |
| Q40230665 | Plasma concentrations of lipids during pregnancy and the risk of gestational diabetes mellitus: A longitudinal study |
| Q42291780 | Positioning about the Flexibility of Fasting for Lipid Profiling. |
| Q55359935 | Postload Glycated Albumin as an Alternate Measure for Diabetes Screening in a Chinese Population. |
| Q37639159 | Postprandial Hyperlipidemia and Remnant Lipoproteins |
| Q64890824 | Postprandial Lipid Concentrations and Daytime Biological Variation of Lipids in a Healthy Chinese Population. |
| Q42363122 | Re-assessing the role of non-fasting lipids; a change in perspective |
| Q93380918 | Reduced plasma levels of small HDL particles transporting fibrinolytic proteins in pulmonary arterial hypertension |
| Q55041188 | Relationship between low-density lipoprotein cholesterol and severe acute pancreatitis ("the lipid paradox"). |
| Q96132301 | Repositioning of the global epicentre of non-optimal cholesterol |
| Q64098522 | Risk assessment of metabolic syndrome in adolescents using the triglyceride/high-density lipoprotein cholesterol ratio and the total cholesterol/high-density lipoprotein cholesterol ratio |
| Q92093383 | Steroid hormone secretion after stimulation of mineralocorticoid and NMDA receptors and cardiovascular risk in patients with depression |
| Q92333057 | The Diagnosis and Treatment of Hypertriglyceridemia |
| Q92804755 | The Effects of a Single Versus Three Consecutive Sessions of Football Training on Postprandial Lipemia: a Randomized, Controlled Trial in Healthy, Recreationally Active Males |
| Q57475802 | The Forgotten Lipids: Triglycerides, Remnant Cholesterol, and Atherosclerotic Cardiovascular Disease Risk |
| Q47763090 | The Future of Low-Density Lipoprotein Cholesterol in an Era of Nonfasting Lipid Testing and Potent Low-Density Lipoprotein Lowering |
| Q61804556 | The association between exposure to different aspects of shift work and metabolic risk factors in health care workers, and the role of chronotype |
| Q47620268 | The influence of dietary and supplemental calcium on postprandial effects of a high-fat meal on lipaemia, glycaemia, C-reactive protein and adiponectin in obese women |
| Q99607572 | The role of postprandial very-low-density lipoprotein in the development of atrial remodeling in metabolic syndrome |
| Q92522639 | The selective peroxisome proliferator-activated receptor alpha modulator (SPPARMα) paradigm: conceptual framework and therapeutic potential : A consensus statement from the International Atherosclerosis Society (IAS) and the Residual Risk Reduction |
| Q50193445 | The year in cardiology 2017: prevention |
| Q89829035 | Time course of metabolic status in pregnant women: The Japan Environment and Children's Study |
| Q88623783 | Treatment target re-classification of subjects comparing estimation of low-density lipoprotein cholesterol by the Friedewald equation and direct measurement of LDL-cholesterol |
| Q49937955 | U-shaped relationship of HDL and risk of infectious disease: two prospective population-based cohort studies |
| Q93107454 | Unaccompanied homeless youth have extremely poor diet quality and nutritional status |
| Q49574252 | Unmet need for primary prevention in individuals with hypertriglyceridaemia not eligible for statin therapy according to European Society of Cardiology/European Atherosclerosis Society guidelines: a contemporary population-based study |
| Q38734430 | Weekday variation in triglyceride concentrations in 1.8 million blood samples |
Search more.